The first stop for professional medicines advice

Articles

690 results

Treating impetigo topically during breastfeeding

21 March 2024Fusidic acid, hydrogen peroxide or mupirocin can be used topically during breastfeeding. Recommendations apply to full term and healthy infants.

Process risk assessments for a Contamination Control Strategy

19 March 2024Performing a Process Risk Assessment (PRA) to inform contamination control strategy for manufacturing processes within NHS units.

Understanding contamination control in pharmacy aseptic services

19 March 2024A co-ordinated approach to preventing microbial contamination ensures that aseptically prepared medicines are safe for patients.

Delegation of roles under a PGD

19 March 2024Delegation of any PGD function is not permitted. However there are specific tasks that individuals other than the professional working under a PGD can fulfil.

Treating rectal and anal disorders during breastfeeding

19 March 2024Rectal and anal topical preparations for haemorrhoids and anal fissures are compatible with breastfeeding. Recommendations apply to full term, healthy infants.

Supporting pharmacists with HRT decision making

13 March 2024This webinar, the first in a series of two, provided an overview of the menopause with a focus around the selection, optimising and stopping of HRT.

Using gastrointestinal antispasmodics during breastfeeding

8 March 2024Hyoscine butylbromide, propantheline or peppermint oil are preferred choices during breastfeeding. Recommendations apply to full term and healthy infants.

Treating insomnia during breastfeeding

8 March 2024Zopiclone and zolpidem are preferred for the short-term management of insomnia during breastfeeding. Recommendations apply to full term and healthy infants.

Good governance when implementing eculizumab biosimilar

6 March 2024Governance should consider processes for approval, procurement and supply, prescribing and administration, monitoring, and pharmacovigilance.

The licence and supporting evidence for eculizumab biosimilars

6 March 2024Two licensed eculizumab biosimilars are available: Bekemv and Epysqli. Learn about the licensed indications, supporting evidence and key differences.